<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>AMD Management Algorithm | Clinical Decision Support</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, sans-serif;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2c3e50;
            line-height: 1.6;
            min-height: 100vh;
        }

        .header {
            background: linear-gradient(135deg, #2c3e50 0%, #1a252f 100%);
            color: white;
            padding: 2rem 0;
            box-shadow: 0 4px 20px rgba(0,0,0,0.1);
            position: relative;
            z-index: 10;
        }

        .header-content {
            max-width: 1200px;
            margin: 0 auto;
            padding: 0 2rem;
            text-align: center;
        }

        .header h1 {
            font-size: 2.5rem;
            margin-bottom: 0.5rem;
            font-weight: 700;
        }

        .header p {
            font-size: 1.1rem;
            opacity: 0.9;
            max-width: 800px;
            margin: 0 auto;
        }

        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 2rem;
            display: flex;
            gap: 2rem;
            position: relative;
        }

        .progress-sidebar {
            position: sticky;
            top: 2rem;
            width: 280px;
            background: white;
            border-radius: 12px;
            box-shadow: 0 4px 20px rgba(0,0,0,0.08);
            padding: 1.5rem;
            height: fit-content;
            border: 1px solid #e9ecef;
        }

        .progress-sidebar h3 {
            font-size: 1.1rem;
            margin-bottom: 1.5rem;
            color: #2c3e50;
            display: flex;
            align-items: center;
            gap: 0.5rem;
            padding-bottom: 0.75rem;
            border-bottom: 2px solid #e9ecef;
        }

        .progress-item {
            display: flex;
            align-items: center;
            gap: 0.75rem;
            padding: 0.75rem;
            margin-bottom: 0.5rem;
            border-radius: 8px;
            cursor: pointer;
            transition: all 0.3s ease;
            opacity: 0.6;
            background: #f8f9fa;
        }

        .progress-item.active {
            opacity: 1;
            background: linear-gradient(135deg, #e3f2fd 0%, #bbdefb 100%);
            box-shadow: 0 2px 8px rgba(33, 150, 243, 0.2);
        }

        .progress-item.completed {
            opacity: 1;
            background: #e8f5e9;
        }

        .progress-icon {
            width: 32px;
            height: 32px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1rem;
            color: white;
            flex-shrink: 0;
        }

        .progress-text {
            font-weight: 500;
            font-size: 0.9rem;
        }

        .main-content {
            flex: 1;
            display: flex;
            flex-direction: column;
            gap: 2rem;
        }

        .card {
            background: white;
            border-radius: 16px;
            box-shadow: 0 6px 24px rgba(0,0,0,0.08);
            overflow: hidden;
            transition: all 0.4s cubic-bezier(0.25, 0.8, 0.25, 1);
            border: 1px solid #e9ecef;
            position: relative;
        }

        .card:hover {
            transform: translateY(-4px);
            box-shadow: 0 12px 32px rgba(0,0,0,0.12);
        }

        .card-header {
            padding: 1.75rem;
            color: white;
            cursor: pointer;
            display: flex;
            justify-content: space-between;
            align-items: center;
            transition: all 0.3s ease;
            position: relative;
            overflow: hidden;
        }

        .card-header::before {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            background: linear-gradient(135deg, rgba(255,255,255,0.1) 0%, rgba(255,255,255,0) 100%);
            pointer-events: none;
        }

        .card-header:hover {
            filter: brightness(1.05);
        }

        .card-header-content {
            display: flex;
            align-items: center;
            gap: 1rem;
            position: relative;
            z-index: 1;
        }

        .card-icon {
            width: 56px;
            height: 56px;
            background: rgba(255,255,255,0.2);
            border-radius: 12px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.75rem;
            backdrop-filter: blur(10px);
            border: 1px solid rgba(255,255,255,0.3);
        }

        .card-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 0.25rem;
        }

        .card-subtitle {
            font-size: 0.95rem;
            opacity: 0.9;
        }

        .expand-icon {
            font-size: 1.5rem;
            transition: transform 0.3s ease;
            opacity: 0.8;
        }

        .card.expanded .expand-icon {
            transform: rotate(180deg);
        }

        .card-content {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.5s ease, padding 0.5s ease;
        }

        .card.expanded .card-content {
            max-height: 2000px;
            padding: 0 1.75rem 1.75rem;
        }

        .card-section {
            margin-bottom: 1.75rem;
        }

        .card-section:last-child {
            margin-bottom: 0;
        }

        .section-title {
            font-size: 1.1rem;
            font-weight: 600;
            margin-bottom: 1rem;
            color: #2c3e50;
            display: flex;
            align-items: center;
            gap: 0.5rem;
            padding-bottom: 0.5rem;
            border-bottom: 2px solid #f1f3f5;
        }

        .section-content {
            font-size: 0.95rem;
            color: #495057;
        }

        .section-content p {
            margin-bottom: 1rem;
        }

        .section-content ul, .section-content ol {
            margin-left: 1.5rem;
            margin-bottom: 1rem;
        }

        .section-content li {
            margin-bottom: 0.5rem;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            gap: 0.5rem;
            padding: 0.4rem 0.8rem;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 600;
            margin: 0.25rem;
            box-shadow: 0 2px 4px rgba(0,0,0,0.1);
            border: 1px solid rgba(0,0,0,0.05);
        }

        .badge-red {
            background: linear-gradient(135deg, #ffebee 0%, #ffcdd2 100%);
            color: #c62828;
        }

        .badge-amber {
            background: linear-gradient(135deg, #fff3e0 0%, #ffe0b2 100%);
            color: #e65100;
        }

        .badge-green {
            background: linear-gradient(135deg, #e8f5e9 0%, #c8e6c9 100%);
            color: #2e7d32;
        }

        .badge-icon {
            font-size: 1rem;
        }

        .risk-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 1rem;
            margin: 1rem 0;
        }

        .risk-item {
            background: #f8f9fa;
            padding: 1rem;
            border-radius: 8px;
            border-left: 4px solid #2196f3;
        }

        .risk-item strong {
            color: #2c3e50;
        }

        .referral-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 1.5rem;
            margin: 1.5rem 0;
        }

        .referral-card {
            background: linear-gradient(135deg, #f5f5f5 0%, #eeeeee 100%);
            padding: 1.5rem;
            border-radius: 12px;
            border: 1px solid #e0e0e0;
            transition: transform 0.2s ease;
        }

        .referral-card:hover {
            transform: translateY(-2px);
        }

        .referral-card h4 {
            color: #2c3e50;
            margin-bottom: 0.75rem;
            font-size: 1.1rem;
            display: flex;
            align-items: center;
            gap: 0.5rem;
        }

        .treatment-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 1.5rem;
            margin: 1.5rem 0;
        }

        .treatment-card {
            background: #f8f9fa;
            padding: 1.5rem;
            border-radius: 12px;
            border: 1px solid #e9ecef;
            transition: all 0.3s ease;
        }

        .treatment-card:hover {
            background: #e3f2fd;
            border-color: #2196f3;
            transform: translateY(-2px);
        }

        .treatment-card h4 {
            color: #2c3e50;
            margin-bottom: 0.75rem;
            font-size: 1.1rem;
            display: flex;
            align-items: center;
            gap: 0.5rem;
        }

        .highlight-box {
            background: linear-gradient(135deg, #e3f2fd 0%, #bbdefb 100%);
            border: 1px solid #90caf9;
            border-radius: 8px;
            padding: 1rem;
            margin: 1rem 0;
        }

        .warning-box {
            background: linear-gradient(135deg, #ffebee 0%, #ffcdd2 100%);
            border: 1px solid #ef9a9a;
            border-radius: 8px;
            padding: 1rem;
            margin: 1rem 0;
        }

        .info-box {
            background: linear-gradient(135deg, #e8f5e9 0%, #c8e6c9 100%);
            border: 1px solid #a5d6a7;
            border-radius: 8px;
            padding: 1rem;
            margin: 1rem 0;
        }

        .code-box {
            background: #2c3e50;
            color: #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            font-family: 'Fira Code', 'Courier New', monospace;
            font-size: 0.85rem;
            overflow-x: auto;
            margin: 1rem 0;
        }

        .code-box strong {
            color: #81c784;
        }

        .code-box em {
            color: #ffeb3b;
            font-style: normal;
        }

        .footer {
            background: #2c3e50;
            color: white;
            padding: 2rem;
            text-align: center;
            margin-top: 3rem;
        }

        .footer p {
            opacity: 0.8;
            font-size: 0.9rem;
        }

        @media (max-width: 768px) {
            .container {
                flex-direction: column;
                padding: 1rem;
            }

            .progress-sidebar {
                width: 100%;
                position: static;
                margin-bottom: 1.5rem;
            }

            .header h1 {
                font-size: 2rem;
            }

            .card-header {
                padding: 1.25rem;
            }

            .card.expanded .card-content {
                padding: 0 1.25rem 1.25rem;
            }

            .referral-grid,
            .treatment-grid,
            .risk-grid {
                grid-template-columns: 1fr;
            }
        }

        .fade-in {
            animation: fadeIn 0.6s ease-out;
        }

        @keyframes fadeIn {
            from {
                opacity: 0;
                transform: translateY(20px);
            }
            to {
                opacity: 1;
                transform: translateY(0);
            }
        }

        .pulse {
            animation: pulse 2s infinite;
        }

        @keyframes pulse {
            0% {
                box-shadow: 0 0 0 0 rgba(244, 67, 54, 0.4);
            }
            70% {
                box-shadow: 0 0 0 10px rgba(244, 67, 54, 0);
            }
            100% {
                box-shadow: 0 0 0 0 rgba(244, 67, 54, 0);
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <div class="header-content">
            <h1>ü©∫ Age-Related Macular Degeneration</h1>
            <p>Interactive Clinical Decision Support Tool | NICE CKS Guidelines (October 2025)</p>
        </div>
    </div>

    <div class="container">
        <div class="progress-sidebar">
            <h3>
                <span>üìç</span>
                Algorithm Progress
            </h3>
            <div class="progress-item active" data-step="assessment">
                <div class="progress-icon" style="background: #3498db;">1</div>
                <div class="progress-text">Assessment</div>
            </div>
            <div class="progress-item" data-step="diagnosis">
                <div class="progress-icon" style="background: #e74c3c;">2</div>
                <div class="progress-text">Diagnosis</div>
            </div>
            <div class="progress-item" data-step="treatment">
                <div class="progress-icon" style="background: #2ecc71;">3</div>
                <div class="progress-text">Treatment</div>
            </div>
            <div class="progress-item" data-step="followup">
                <div class="progress-icon" style="background: #f39c12;">4</div>
                <div class="progress-text">Follow-up</div>
            </div>
        </div>

        <div class="main-content">
            <!-- ASSESSMENT CARD -->
            <div class="card fade-in" id="assessment-card">
                <div class="card-header" style="background: linear-gradient(135deg, #3498db 0%, #2980b9 100%);">
                    <div class="card-header-content">
                        <div class="card-icon">üëÅÔ∏è</div>
                        <div>
                            <div class="card-title">Assessment</div>
                            <div class="card-subtitle">Initial Evaluation & Risk Stratification</div>
                        </div>
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-content">
                    <div class="card-section">
                        <div class="section-title">
                            <span>üìù</span> When to Suspect AMD
                        </div>
                        <div class="section-content">
                            <p><strong>Typical presentation in people aged ‚â•50 years:</strong></p>
                            <ul>
                                <li>Blurring or distortion of vision (metamorphopsia)</li>
                                <li>Scotoma (black/grey patch in central vision)</li>
                                <li>Difficulty reading or seeing fine detail</li>
                                <li>Objects appearing different in size/color between eyes</li>
                                <li>Photopsia (flickering/flashing lights)</li>
                                <li>Rapid visual deterioration (suggests neovascular AMD)</li>
                                <li>Gradual visual loss (suggests geographic atrophy)</li>
                                <li>Visual hallucinations (Charles Bonnet syndrome) may occur</li>
                            </ul>
                            
                            <div class="warning-box">
                                <strong>‚ö†Ô∏è Key Point:</strong> Patients may be asymptomatic with retinal signs detected incidentally during routine eye tests.
                            </div>
                        </div>
                    </div>

                    <div class="card-section">
                        <div class="section-title">
                            <span>‚ö†Ô∏è</span> Red Flag Symptoms
                        </div>
                        <div class="section-content">
                            <div class="badge badge-red pulse">
                                <span class="badge-icon">üö®</span>
                                URGENT: Sudden vision changes or distortion - consider neovascular AMD
                            </div>
                        </div>
                    </div>

                    <div class="card-section">
                        <div class="section-title">
                            <span>üë§</span> Risk Factors
                        </div>
                        <div class="section-content">
                            <div class="risk-grid">
                                <div class="risk-item">
                                    <strong>üî∫ Non-modifiable:</strong>
                                    <ul>
                                        <li>Increasing age (especially >75 years)</li>
                                        <li>Female sex</li>
                                        <li>Family history (71% heritability)</li>
                                        <li>Northern European ancestry</li>
                                    </ul>
                                </div>
                                <div class="risk-item">
                                    <strong>üîß Modifiable:</strong>
                                    <ul>
                                        <li>SMOKING (strongest modifiable risk)</li>
                                        <li>Hypertension</li>
                                        <li>Cardiovascular disease</li>
                                        <li>Obesity (BMI ‚â•30 kg/m¬≤)</li>
                                        <li>Poor diet (low omega-3, vitamins, high saturated fat)</li>
                                        <li>Physical inactivity</li>
                                    </ul>
                                </div>
                            </div>
                            
                            <div class="highlight-box">
                                <strong>üí° Smoking Cessation:</strong> Stopping smoking reduces AMD progression risk. After 20 years smoke-free, risk equals non-smokers.
                            </div>
                        </div>
                    </div>

                    <div class="card-section">
                        <div class="section-title">
                            <span>üîç</span> Examination Findings
                        </div>
                        <div class="section-content">
                            <p><strong>Visual acuity:</strong> May be reduced, but can be normal in early stages</p>
                            <p><strong>Fundoscopy findings:</strong></p>
                            <ul>
                                <li><strong>Drusen:</strong> Pale yellow spots on retina (early stage)</li>
                                <li><strong>Pigmentary changes:</strong> Hypo/hyperpigmentation</li>
                                <li><strong>Geographic atrophy:</strong> Sharply demarcated depigmented areas</li>
                                <li><strong>Exudative/hemorrhagic changes:</strong> Suggest neovascular AMD</li>
                            </ul>
                            <div class="info-box">
                                <strong>üìå Note:</strong> Signs may be difficult to detect in primary care depending on expertise. When in doubt, refer for specialist assessment.
                            </div>
                        </div>
                    </div>

                    <div class="card-section">
                        <div class="section-title">
                            <span>üìä</span> Classification
                        </div>
                        <div class="section-content">
                            <p><strong>NICE Classification System:</strong></p>
                            <ul>
                                <li><strong>No AMD:</strong> No signs or small drusen (<63Œºm)</li>
                                <li><strong>Early AMD:</strong> Medium drusen (63-124Œºm) or pigmentary abnormalities</li>
                                <li><strong>Intermediate AMD:</strong> Large drusen (‚â•125Œºm) or reticular drusen with pigmentary changes</li>
                                <li><strong>Late AMD:</strong>
                                    <ul>
                                        <li>Wet active: Choroidal neovascularization (CNV)</li>
                                        <li>Dry: Geographic atrophy</li>
                                        <li>Intermediate: RPE dysfunction without neovascularization</li>
                                    </ul>
                                </li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>

            <!-- DIAGNOSIS CARD -->
            <div class="card fade-in" id="diagnosis-card">
                <div class="card-header" style="background: linear-gradient(135deg, #e74c3c 0%, #c0392b 100%);">
                    <div class="card-header-content">
                        <div class="card-icon">üî¨</div>
                        <div>
                            <div class="card-title">Diagnosis</div>
                            <div class="card-subtitle">Confirmation & Differential Diagnosis</div>
                        </div>
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-content">
                    <div class="card-section">
                        <div class="section-title">
                            <span>üè•</span> Primary Care Actions
                        </div>
                        <div class="section-content">
                            <div class="badge badge-red">
                                <span class="badge-icon">‚è±Ô∏è</span>
                                URGENT REFERRAL: Within 1 working day if neovascular AMD suspected
                            </div>
                            
                            <div class="referral-grid">
                                <div class="referral-card">
                                    <h4><span>üö®</span> Emergency Pathway</h4>
                                    <p><strong>Indication:</strong> Suspected neovascular AMD</p>
                                    <p><strong>Timeline:</strong> Within <strong>1 working day</strong></p>
                                    <p><strong>Destination:</strong> Specialist AMD service, fast-track macular clinic, or hospital eye emergency department</p>
                                </div>
                                <div class="referral-card">
                                    <h4><span>üìÖ</span> Routine Pathway</h4>
                                    <p><strong>Indication:</strong> Other suspected AMD</p>
                                    <p><strong>Timeline:</strong> Within <strong>1 week</strong> to optometrist</p>
                                    <p><strong>Action:</strong> Direct referral to ophthalmologist if neovascular AMD identified</p>
                                </div>
                            </div>

                            <div class="warning-box">
                                <strong>‚ö†Ô∏è Patient Advice:</strong> If delay >1 week or symptoms worsen while waiting, advise immediate attendance at Eye Casualty or seek urgent medical attention.
                            </div>
                        </div>
                    </div>

                    <div class="card-section">
                        <div class="section-title">
                            <span>üî¨</span> Secondary Care Investigations
                        </div>
                        <div class="section-content">
                            <ul>
                                <li><strong>Slit-lamp biomicroscopy:</strong> Identify drusen, pigmentary/exudative/hemorrhagic/atrophic changes</li>
                                <li><strong>Optical Coherence Tomography (OCT):</strong> <span class="badge badge-red">MANDATORY</span> for diagnosis and monitoring</li>
                                <li><strong>Colour fundus photography:</strong> Document retinal appearance</li>
                                <li><strong>Fundus autofluorescence:</strong> Visualize geographic atrophy progression</li>
                                <li><strong>Fluorescein angiography:</strong> Confirm neovascular AMD, assess lesion type/extent</li>
                                <li><strong>Indocyanine green angiography:</strong> Visualize choroidal circulation</li>
                            </ul>
                        </div>
                    </div>

                    <div class="card-section">
                        <div class="section-title">
                            <span>‚ùì</span> Differential Diagnosis
                        </div>
                        <div class="section-content">
                            <p><strong>Conditions causing painless visual disturbance:</strong></p>
                            <ul>
                                <li>Refractive error</li>
                                <li>Corneal disease (e.g., Fuch's dystrophy)</li>
                                <li>Cataract</li>
                                <li>Primary open-angle glaucoma</li>
                                <li>Posterior vitreous detachment/vitreous hemorrhage/retinal detachment</li>
                                <li>Cerebrovascular disease (amaurosis fugax, stroke/TIA)</li>
                                <li>Retinal arterial/venous occlusion</li>
                                <li>Medication toxicity (e.g., hydroxychloroquine, ethambutol)</li>
                                <li>Pituitary tumor/papilledema</li>
                            </ul>
                            
                            <p><strong>Conditions with similar retinal signs:</strong></p>
                            <ul>
                                <li>Diabetic maculopathy</li>
                                <li>High myopia with CNV (younger age, different natural history)</li>
                                <li>Inflammatory syndromes causing CNV (with uveitis signs)</li>
                                <li>Central serous retinopathy</li>
                                <li>Macular telangiectasia</li>
                                <li>Pattern dystrophy</li>
                                <li>Macular hole</li>
                            </ul>
                            
                            <div class="info-box">
                                <strong>üí° Tip:</strong> Consider hereditary macular dystrophies in patients <50 years with AMD-like features.
                            </div>
                        </div>
                    </div>

                    <div class="card-section">
                        <div class="section-title">
                            <span>üìã</span> Diagnostic Criteria
                        </div>
                        <div class="section-content">
                            <p><strong>AMD is characterized by:</strong></p>
                            <ul>
                                <li>Drusen (‚â•63Œºm diameter) - intermediate or large</li>
                                <li>RPE abnormalities (hypo/hyperpigmentation)</li>
                                <li>Geographic atrophy (RPE breakdown)</li>
                                <li>Choroidal neovascularization (CNV)</li>
                                <li>Polypoidal choroidal vasculopathy (PCV)</li>
                                <li>Reticular pseudodrusen</li>
                                <li>Retinal angiomatous proliferation</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>

            <!-- TREATMENT CARD -->
            <div class="card fade-in" id="treatment-card">
                <div class="card-header" style="background: linear-gradient(135deg, #2ecc71 0%, #27ae60 100%);">
                    <div class="card-header-content">
                        <div class="card-icon">üíä</div>
                        <div>
                            <div class="card-title">Treatment</div>
                            <div class="card-subtitle">Management & Secondary Care Treatments</div>
                        </div>
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-content">
                    <div class="card-section">
                        <div class="section-title">
                            <span>üè†</span> Primary Care Management
                        </div>
                        <div class="section-content">
                            <p><strong>For Suspected AMD:</strong></p>
                            <ul>
                                <li>Urgent referral if neovascular AMD suspected (within 1 working day)</li>
                                <li>Arrange optometrist review within 1 week for other cases</li>
                                <li>Provide advice on symptoms requiring immediate attention</li>
                            </ul>
                            
                            <p><strong>For Confirmed AMD:</strong></p>
                            <div class="treatment-grid">
                                <div class="treatment-card">
                                    <h4><span>üö≠</span> Lifestyle Interventions</h4>
                                    <ul>
                                        <li>Smoking cessation (strongly advised)</li>
                                        <li>Healthy balanced diet:
                                            <ul>
                                                <li>Low glycaemic index</li>
                                                <li>Rich in fruits & green leafy vegetables</li>
                                                <li>High in omega-3 fatty acids (fish)</li>
                                                <li>Low saturated fat & cholesterol</li>
                                            </ul>
                                        </li>
                                        <li>Control hypertension & cardiovascular risk</li>
                                    </ul>
                                </div>
                                <div class="treatment-card">
                                    <h4><span>üíä</span> Nutritional Supplements</h4>
                                    <p><strong>AREDS2 formulation for:</strong></p>
                                    <ul>
                                        <li>Intermediate AMD in one/both eyes</li>
                                        <li>Advanced AMD in one eye</li>
                                    </ul>
                                    <div class="code-box">
                                        <strong>AREDS2 Composition:</strong><br>
                                        ‚Ä¢ Vitamin C 500 mg<br>
                                        ‚Ä¢ Vitamin E 400 IU<br>
                                        ‚Ä¢ Lutein 10 mg<br>
                                        ‚Ä¢ Zeaxanthin 2 mg<br>
                                        ‚Ä¢ Zinc 25 mg<br>
                                        ‚Ä¢ Copper 2 mg (cupric oxide)
                                    </div>
                                    <div class="badge badge-amber">
                                        <span class="badge-icon">‚ö†Ô∏è</span>
                                        Not for primary prevention or early AMD
                                    </div>
                                </div>
                            </div>
                            
                            <div class="warning-box">
                                <strong>‚ö†Ô∏è Supplement Risks:</strong>
                                <ul>
                                    <li>Zinc: Small increased risk of genito-urinary hospitalization</li>
                                    <li>Vitamin E: Possible increased heart failure risk in diabetes/vascular disease</li>
                                    <li>Beta-carotene: Increased lung cancer risk in smokers (NOT recommended)</li>
                                </ul>
                            </div>
                        </div>
                    </div>

                    <div class="card-section">
                        <div class="section-title">
                            <span>üè•</span> Secondary Care Treatments
                        </div>
                        <div class="section-content">
                            <h4 style="margin-bottom: 1rem; color: #2c3e50;">1. Anti-VEGF Therapy (First-line)</h4>
                            <div class="treatment-grid">
                                <div class="treatment-card">
                                    <h4><span>üíâ</span> Anti-VEGF Agents</h4>
                                    <ul>
                                        <li>Ranibizumab (Lucentis¬Æ)</li>
                                        <li>Ranibizumab biosimilars (Byooviz¬Æ, Ongavia¬Æ, Rimmyrah¬Æ, Ximluci¬Æ)</li>
                                        <li>Bevacizumab (Avastin¬Æ - off-label)</li>
                                        <li>Aflibercept (Eylea¬Æ)</li>
                                        <li>Faricimab (Vabysmo¬Æ)</li>
                                        <li>Brolucizumab (Beovu¬Æ)</li>
                                        <li><strong>New:</strong> Aflibercept (Mynzepli¬Æ) 40 mg/mL</li>
                                    </ul>
                                </div>
                                <div class="treatment-card">
                                    <h4><span>üìÖ</span> Treatment Regimen</h4>
                                    <ul>
                                        <li>Intravitreal injection</li>
                                        <li>Loading phase: Regular injections</li>
                                        <li>Maintenance: Variable intervals based on response</li>
                                        <li>Duration: May continue for ‚â•2 years</li>
                                        <li>Monitoring: Mandatory OCT assessment</li>
                                    </ul>
                                </div>
                            </div>

                            <h4 style="margin: 1.5rem 0 1rem; color: #2c3e50;">2. Older Treatments (Second-line/Specific Cases)</h4>
                            <div class="treatment-grid">
                                <div class="treatment-card">
                                    <h4><span>‚ö°</span> Laser Photocoagulation</h4>
                                    <p>Destroys new blood vessels. Creates permanent scotoma. Only for lesions not close to foveal center.</p>
                                </div>
                                <div class="treatment-card">
                                    <h4><span>üåü</span> Photodynamic Therapy (PDT)</h4>
                                    <p>Verteporfin injection + laser treatment. Second-line in combination with anti-VEGF for wet active AMD.</p>
                                </div>
                            </div>

                            <h4 style="margin: 1.5rem 0 1rem; color: #2c3e50;">3. Geographic Atrophy Treatment</h4>
                            <div class="warning-box">
                                <strong>‚ö†Ô∏è Limited Treatment Options:</strong> Mainly counseling, smoking cessation, visual rehabilitation, and nutritional supplements (as above).
                            </div>
                        </div>
                    </div>

                    <div class="card-section">
                        <div class="section-title">
                            <span>üöó</span> Driving Advice
                        </div>
                        <div class="section-content">
                            <ul>
                                <li><strong>One eye affected:</strong> No need to inform DVLA if visual standards for driving met</li>
                                <li><strong>Both eyes affected:</strong> Must inform DVLA</li>
                                <li><strong>Patient responsibility:</strong> To ensure eyesight meets legal standards</li>
                            </ul>
                            <div class="info-box">
                                <strong>üí° DVLA Guidance:</strong> Refer to "Assessing fitness to drive - a guide for medical professionals" if uncertain.
                            </div>
                        </div>
                    </div>

                    <div class="card-section">
                        <div class="section-title">
                            <span>ü§ù</span> Support & Rehabilitation
                        </div>
                        <div class="section-content">
                            <div class="treatment-grid">
                                <div class="treatment-card">
                                    <h4><span>üìú</span> Certification</h4>
                                    <p>Offer certificate of visual impairment as soon as eligible, even during active treatment. Explain benefits and entitlements.</p>
                                </div>
                                <div class="treatment-card">
                                    <h4><span>üîç</span> Low Vision Services</h4>
                                    <p>Refer for optical aids (magnifiers), lighting advice, electronic aids, and non-optical aids. No registration required.</p>
                                </div>
                                <div class="treatment-card">
                                    <h4><span>üë•</span> Rehabilitation</h4>
                                    <p>Group-based programs to promote independent living. Eccentric viewing training for bilateral central vision loss.</p>
                                </div>
                                <div class="treatment-card">
                                    <h4><span>üß†</span> Psychological Support</h4>
                                    <p>Screen for depression (up to 44% in advanced AMD). Optimize management of comorbidities.</p>
                                </div>
                            </div>

                            <div class="highlight-box">
                                <strong>üìû Key Resources:</strong>
                                <ul style="margin-top: 0.5rem;">
                                    <li><strong>Macular Society:</strong> www.macularsociety.org (support & information)</li>
                                    <li><strong>RNIB:</strong> www.rnib.org.uk (information, support, local groups)</li>
                                    <li><strong>Citizens Advice:</strong> Benefits advice</li>
                                    <li><strong>NHS England Decision Support Tool</strong></li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- FOLLOW-UP CARD -->
            <div class="card fade-in" id="followup-card">
                <div class="card-header" style="background: linear-gradient(135deg, #f39c12 0%, #d35400 100%);">
                    <div class="card-header-content">
                        <div class="card-icon">üìà</div>
                        <div>
                            <div class="card-title">Follow-up</div>
                            <div class="card-subtitle">Monitoring & Self-Management</div>
                        </div>
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-content">
                    <div class="card-section">
                        <div class="section-title">
                            <span>üëÅÔ∏è</span> Self-Monitoring
                        </div>
                        <div class="section-content">
                            <p><strong>Discuss self-monitoring strategies with all AMD patients:</strong></p>
                            
                            <div class="treatment-grid">
                                <div class="treatment-card">
                                    <h4><span>üìê</span> Amsler Grid</h4>
                                    <ul>
                                        <li>Graph paper with central fixation dot</li>
                                        <li>View central spot, evaluate for grid distortion</li>
                                        <li>Simple, cost-effective home monitoring tool</li>
                                    </ul>
                                </div>
                                <div class="treatment-card">
                                    <h4><span>üì±</span> Electronic Monitoring</h4>
                                    <p>Digital apps and devices for home monitoring of visual changes</p>
                                </div>
                            </div>

                            <div class="warning-box">
                                <strong>üö® Report Immediately If:</strong>
                                <ul>
                                    <li>New blurred or grey patch in vision</li>
                                    <li>Straight lines appear distorted (metamorphopsia)</li>
                                    <li>Objects appear smaller than normal</li>
                                    <li>Any sudden change in vision</li>
                                </ul>
                            </div>

                            <p><strong>For patients lacking confidence:</strong></p>
                            <ul>
                                <li>Encourage and support self-monitoring efforts</li>
                                <li>Discuss monitoring techniques with family/carers</li>
                                <li>Provide clear written instructions</li>
                            </ul>
                        </div>
                    </div>

                    <div class="card-section">
                        <div class="section-title">
                            <span>‚è∞</span> When to Seek Help
                        </div>
                        <div class="section-content">
                            <div class="badge badge-red pulse" style="margin-bottom: 1rem;">
                                <span class="badge-icon">üö®</span>
                                IMMEDIATE: Present to Eye Casualty or urgent specialist clinic
                            </div>
                            <ul>
                                <li>Sudden change in vision in either eye</li>
                                <li>Development of symptoms in the second eye</li>
                                <li>Rapid deterioration while on treatment</li>
                                <li>New distortion or scotoma</li>
                            </ul>
                            
                            <div class="badge badge-green">
                                <span class="badge-icon">üìÖ</span>
                                ROUTINE: Continue regular sight tests with community optometrist
                            </div>
                        </div>
                    </div>

                    <div class="card-section">
                        <div class="section-title">
                            <span>üìà</span> Prognosis & Monitoring
                        </div>
                        <div class="section-content">
                            <h4 style="margin-bottom: 1rem; color: #2c3e50;">Disease Progression Rates:</h4>
                            <div class="treatment-grid">
                                <div class="treatment-card">
                                    <h4><span>üìä</span> Early AMD ‚Üí Advanced AMD</h4>
                                    <ul>
                                        <li>5-year risk: <strong>1.3%</strong></li>
                                        <li>10-year progression to large drusen: ~15%</li>
                                    </ul>
                                </div>
                                <div class="treatment-card">
                                    <h4><span>üìä</span> Intermediate AMD ‚Üí Advanced AMD</h4>
                                    <ul>
                                        <li>5-year risk: <strong>~18%</strong></li>
                                        <li>With large drusen: 6.3% at 5 years</li>
                                        <li>Bilateral large drusen: 26% at 5 years</li>
                                    </ul>
                                </div>
                                <div class="treatment-card">
                                    <h4><span>üëÅÔ∏è</span> Second Eye Involvement</h4>
                                    <ul>
                                        <li>5-year risk: 22-50%</li>
                                        <li>Neovascular AMD: 12% at 1 year, 27% at 4 years</li>
                                    </ul>
                                </div>
                                <div class="treatment-card">
                                    <h4><span>üìà</span> Geographic Atrophy Progression</h4>
                                    <ul>
                                        <li>2 years: 31% lose 3 lines of vision</li>
                                        <li>4 years: 53% lose 3 lines of vision</li>
                                        <li>Doubling of visual angle in up to 50% over 2 years</li>
                                    </ul>
                                </div>
                            </div>

                            <h4 style="margin: 1.5rem 0 1rem; color: #2c3e50;">Treated Neovascular AMD:</h4>
                            <div class="info-box">
                                <strong>7-year follow-up data:</strong>
                                <ul>
                                    <li>43% maintained or improved visual acuity</li>
                                    <li>34% lost ‚â•3 lines on visual acuity chart</li>
                                    <li>Factors affecting outcome: VA and lesion size at diagnosis, number of injections received</li>
                                </ul>
                            </div>

                            <div class="warning-box">
                                <strong>‚ö†Ô∏è Untreated Neovascular AMD:</strong>
                                <ul>
                                    <li>3 months: 1 line lost</li>
                                    <li>12 months: ~3 lines lost</li>
                                    <li>24 months: ~4 lines lost</li>
                                    <li>Rapid progression to moderate/severe visual loss within weeks/months</li>
                                </ul>
                            </div>
                        </div>
                    </div>

                    <div class="card-section">
                        <div class="section-title">
                            <span>üîÑ</span> Complications to Monitor
                        </div>
                        <div class="section-content">
                            <div class="treatment-grid">
                                <div class="treatment-card">
                                    <h4><span>üëÅÔ∏è</span> AMD Complications</h4>
                                    <ul>
                                        <li>Visual impairment/blindness</li>
                                        <li>Depression (up to 44% in advanced AMD)</li>
                                        <li>Charles Bonnet syndrome (visual hallucinations)</li>
                                        <li>Falls and fractures</li>
                                        <li>Reduced quality of life</li>
                                        <li>Limitations in daily activities</li>
                                    </ul>
                                </div>
                                <div class="treatment-card">
                                    <h4><span>üíâ</span> Treatment Complications</h4>
                                    <ul>
                                        <li>Endophthalmitis (post-injection)</li>
                                        <li>Traumatic lens injury</li>
                                        <li>Retinal detachment</li>
                                        <li>Photosensitivity (post-PDT)</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </div>

                    <div class="card-section">
                        <div class="section-title">
                            <span>üéØ</span> NICE Quality Standards
                        </div>
                        <div class="section-content">
                            <div class="highlight-box">
                                <strong>QS180: Serious Eye Disorders</strong>
                                <ul style="margin-top: 0.5rem;">
                                    <li>Adults with wet active AMD start treatment within <strong>14 days</strong> of referral to macular service</li>
                                    <li>Adults with wet active AMD have <strong>both eyes monitored</strong></li>
                                    <li>Adults with serious eye disorders receive certificate of vision impairment when eligible</li>
                                </ul>
                            </div>
                        </div>
                    </div>

                    <div class="card-section">
                        <div class="section-title">
                            <span>üìö</span> Patient Education Checklist
                        </div>
                        <div class="section-content">
                            <ul>
                                <li>‚úÖ Explanation of AMD type and prognosis</li>
                                <li>‚úÖ Information on secondary care investigations</li>
                                <li>‚úÖ Treatment options, benefits, and risks</li>
                                <li>‚úÖ Lifestyle advice (smoking cessation, diet)</li>
                                <li>‚úÖ Driving regulations and DVLA requirements</li>
                                <li>‚úÖ Self-monitoring techniques (Amsler grid)</li>
                                <li>‚úÖ When and how to seek urgent help</li>
                                <li>‚úÖ Low vision services and rehabilitation options</li>
                                <li>‚úÖ Psychological support resources</li>
                                <li>‚úÖ Benefits and entitlements information</li>
                                <li>‚úÖ Support group contacts (Macular Society, RNIB)</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <div class="footer">
        <p>Based on NICE Clinical Knowledge Summaries: Age-related macular degeneration (October 2025)</p>
        <p>For healthcare professionals in NHS primary care setting | Not a substitute for clinical judgment</p>
    </div>

    <script>
        // Card expansion functionality
        document.querySelectorAll('.card-header').forEach(header => {
            header.addEventListener('click', () => {
                const card = header.parentElement;
                const isExpanded = card.classList.contains('expanded');
                
                // Close all cards
                document.querySelectorAll('.card').forEach(c => {
                    c.classList.remove('expanded');
                    c.querySelector('.expand-icon').style.transform = 'rotate(0deg)';
                });
                
                // Open clicked card if it wasn't already expanded
                if (!isExpanded) {
                    card.classList.add('expanded');
                    header.querySelector('.expand-icon').style.transform = 'rotate(180deg)';
                    
                    // Scroll to card
                    setTimeout(() => {
                        card.scrollIntoView({ 
                            behavior: 'smooth', 
                            block: 'start',
                            inline: 'nearest'
                        });
                    }, 100);
                }
                
                updateProgress();
            });
            
            // Initialize first card as expanded
            if (header.parentElement.id === 'assessment-card') {
                header.click();
            }
        });

        // Progress sidebar functionality
        function updateProgress() {
            const cards = document.querySelectorAll('.card');
            const progressItems = document.querySelectorAll('.progress-item');
            
            cards.forEach((card, index) => {
                const isExpanded = card.classList.contains('expanded');
                const isCompleted = isCardCompleted(card);
                
                progressItems[index].classList.remove('active', 'completed');
                
                if (isExpanded) {
                    progressItems[index].classList.add('active');
                } else if (isCompleted) {
                    progressItems[index].classList.add('completed');
                }
            });
        }

        function isCardCompleted(card) {
            // Simple check: if card has been expanded before, mark as completed
            return card.dataset.visited === 'true';
        }

        // Mark cards as visited when expanded
        document.querySelectorAll('.card-header').forEach(header => {
            header.addEventListener('click', () => {
                const card = header.parentElement;
                card.dataset.visited = 'true';
                updateProgress();
            });
        });

        // Progress item click navigation
        document.querySelectorAll('.progress-item').forEach((item, index) => {
            item.addEventListener('click', () => {
                const targetCard = document.querySelectorAll('.card')[index];
                const header = targetCard.querySelector('.card-header');
                
                // Close all cards
                document.querySelectorAll('.card').forEach(c => {
                    c.classList.remove('expanded');
                    c.querySelector('.expand-icon').style.transform = 'rotate(0deg)';
                });
                
                // Open target card
                targetCard.classList.add('expanded');
                targetCard.querySelector('.expand-icon').style.transform = 'rotate(180deg)';
                targetCard.dataset.visited = 'true';
                
                // Scroll to card
                setTimeout(() => {
                    targetCard.scrollIntoView({ 
                        behavior: 'smooth', 
                        block: 'start',
                        inline: 'nearest'
                    });
                }, 100);
                
                updateProgress();
            });
        });

        // Smooth scroll for internal links
        document.querySelectorAll('a[href^="#"]').forEach(anchor => {
            anchor.addEventListener('click', function (e) {
                e.preventDefault();
                const target = document.querySelector(this.getAttribute('href'));
                if (target) {
                    target.scrollIntoView({ behavior: 'smooth', block: 'start' });
                }
            });
        });

        // Add animation to cards on scroll
        const observerOptions = {
            threshold: 0.1,
            rootMargin: '0px 0px -50px 0px'
        };

        const observer = new IntersectionObserver((entries) => {
            entries.forEach(entry => {
                if (entry.isIntersecting) {
                    entry.target.classList.add('fade-in');
                }
            });
        }, observerOptions);

        document.querySelectorAll('.card').forEach(card => {
            observer.observe(card);
        });

        // Badge interaction effects
        document.querySelectorAll('.badge').forEach(badge => {
            badge.addEventListener('mouseenter', function() {
                this.style.transform = 'scale(1.05)';
                this.style.transition = 'transform 0.2s ease';
            });
            
            badge.addEventListener('mouseleave', function() {
                this.style.transform = 'scale(1)';
            });
        });

        // Print functionality
        function printAlgorithm() {
            window.print();
        }

        // Add print button (optional - can be triggered via browser)
        document.addEventListener('keydown', (e) => {
            if (e.ctrlKey && e.key === 'p') {
                e.preventDefault();
                printAlgorithm();
            }
        });

        // Initialize on load
        document.addEventListener('DOMContentLoaded', () => {
            updateProgress();
            
            // Add keyboard navigation
            document.addEventListener('keydown', (e) => {
                const cards = document.querySelectorAll('.card');
                const activeCard = document.querySelector('.card.expanded');
                const currentIndex = Array.from(cards).indexOf(activeCard);
                
                if (e.key === 'ArrowDown' && currentIndex < cards.length - 1) {
                    e.preventDefault();
                    document.querySelectorAll('.progress-item')[currentIndex + 1].click();
                } else if (e.key === 'ArrowUp' && currentIndex > 0) {
                    e.preventDefault();
                    document.querySelectorAll('.progress-item')[currentIndex - 1].click();
                }
            });
        });

        // Responsive behavior for mobile
        function handleResize() {
            const sidebar = document.querySelector('.progress-sidebar');
            const container = document.querySelector('.container');
            
            if (window.innerWidth <= 768) {
                sidebar.style.position = 'static';
                container.style.flexDirection = 'column';
            } else {
                sidebar.style.position = 'sticky';
                container.style.flexDirection = 'row';
            }
        }

        window.addEventListener('resize', handleResize);
        handleResize(); // Call on load

        // Accessibility improvements
        document.querySelectorAll('.card-header').forEach(header => {
            header.setAttribute('tabindex', '0');
            header.setAttribute('role', 'button');
            header.setAttribute('aria-expanded', 'false');
            
            header.addEventListener('keydown', (e) => {
                if (e.key === 'Enter' || e.key === ' ') {
                    e.preventDefault();
                    header.click();
                }
            });
            
            header.addEventListener('click', () => {
                const expanded = header.parentElement.classList.contains('expanded');
                header.setAttribute('aria-expanded', expanded);
            });
        });

        // Add focus styles for keyboard navigation
        const style = document.createElement('style');
        style.textContent = `
            .card-header:focus {
                outline: 3px solid #3498db;
                outline-offset: 2px;
            }
            .progress-item:focus {
                outline: 3px solid #3498db;
                outline-offset: 2px;
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>